ADVERTISEMENT
ADVERTISEMENT
A photo of a 96-well microplate showcasing serial dilutions of purple dye solution.
Achieving Consistency in Serial Dilutions
Researchers ensure the success of their serial dilution-based assays by using optimized protocols and advanced liquid handling tools.
Achieving Consistency in Serial Dilutions
Achieving Consistency in Serial Dilutions

Researchers ensure the success of their serial dilution-based assays by using optimized protocols and advanced liquid handling tools.

Researchers ensure the success of their serial dilution-based assays by using optimized protocols and advanced liquid handling tools.

drug screening

Images of tumor organoids acquired using high-speed live cell interferometry.
Evaluating Tumor Heterogeneity with a High Throughput Pipeline
Charlene Lancaster, PhD | Jun 3, 2024 | 3 min read
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
iStock
Explainable AI for Rational Antibiotic Discovery
The Scientist | Apr 24, 2024 | 1 min read
Researchers tackle the antibiotic resistance crisis with explainable neural networks and high throughput drug discovery.
Conceptual image of scientific advancement depicting a large spherical object and wire frame image of a running human.
Organoids: The New Frontier
The Scientist | Nov 22, 2023 | 1 min read
Explore the latest in organoid production for studying development, disease, and drug screening.
Advancing Drug Discovery by Employing Synthetic Biology Tools
Advancing Drug Discovery by Employing Synthetic Biology Tools
The Scientist | Oct 18, 2023 | 1 min read
In this webinar, learn about the origins of artificial gene circuits and how researchers currently use synthetic biology strategies to uncover new drugs. 
ConPlex predicts what proteins a drug is likely to bind, which can help identify new targets for existing drugs.
Simplifying the Search for Drug Targets
Aparna Nathan, PhD | Aug 1, 2023 | 3 min read
A new machine learning model promises fast prediction of drug-target interactions.
ADVERTISEMENT